drugset / Trial / NCT01939314
Sphenopalatine Nerve Block for Headache Tx360
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary objective of this study is to evaluate the efficacy of sphenopalatine nerve block utilizing the Tx360 (device) to deliver an anesthetic agent (bupivacaine) and to assess the duration of the analgesia.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.03 ml | Intranasal |